Hemab Therapeutics Holdings Common Stock Total Assets

As of the most recent data (June 2026), COAG shows a total assets of $470M. Scroll down for historical charts and peer comparison views.

Tracking COAG's total assets over time shows whether Hemab Therapeutics Holdings Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $470M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Hemab Therapeutics Holdings Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $470M) with ownership activity and broader fundamentals.

Hemab Therapeutics Holdings Common Stock's total assets is $470M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.